despit
increas
recognit
role
virus
caus
pneumonia
adult
either
sole
pathogen
copathogen
bacteria
diagnosi
treatment
viral
pneumonia
remain
difficult
clinic
problem
progress
made
develop
precis
laboratori
test
diagnos
lower
respiratori
tract
infect
viral
origin
wider
avail
test
like
spur
recognit
give
impetu
develop
new
therapi
proport
pneumonia
adult
caus
virus
difficult
quantifi
precis
lack
certainti
surpris
approxim
pneumonia
identifi
pathogen
establish
convent
laboratori
test
molecular
techniqu
polymeras
chain
reaction
pcr
analysi
improv
number
rare
perform
routin
clinic
care
difficulti
obtain
adequ
specimen
viral
cultur
molecular
test
add
problem
howev
sever
recent
studi
made
effort
quantifi
burden
viral
communityacquir
pneumonia
adult
summar
tabl
although
proport
viral
pneumonia
vari
studi
owe
differ
studi
popul
rigor
test
virus
clear
virus
caus
signific
proport
pneumonia
overal
immunocompet
adult
hospit
pneumonia
virus
respons
pathogen
case
either
copathogen
bacteria
lower
respiratori
secret
bronchoalveolar
lavag
bal
fluid
tracheal
aspir
goodqual
induc
sputum
prefer
specimen
diagnosi
viral
pneumonia
specimen
difficult
obtain
howev
studi
use
nasopharyng
wash
sampl
swab
cultur
molecular
test
presenc
establish
pathogen
influenza
viru
upper
respiratori
tract
sampl
patient
pneumonia
probabl
impli
viru
sole
copathogen
causat
pneumonia
howev
gener
rule
may
applic
virus
presenc
virus
rhinoviru
might
impli
upper
respiratori
infect
patient
pneumonia
due
anoth
pathogen
find
studi
viral
pneumonia
must
therefor
interpret
caution
patient
undergon
hematopoiet
stem
cell
transplant
hsct
solid
organ
transplant
undergo
intens
chemotherapi
leukemia
exhibit
higher
incid
viral
upper
respiratori
infect
normal
control
subject
well
frequent
involv
lower
respiratori
tract
sever
pneumonia
higher
rate
death
viral
pneumonia
pathogen
mention
tabl
repres
patient
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
usual
caus
mild
ill
immunocompet
person
caus
sever
pneumonia
high
mortal
rate
highrisk
patient
popul
extrapulmonari
manifest
influenza
infect
myocard
unusu
popul
rsv
common
viral
pathogen
lower
respiratori
tract
patient
undergon
hematopoiet
stem
cell
solid
organ
transplant
report
mani
seri
fulmin
dissemin
adenovir
infect
report
patient
advanc
human
immunodefici
viru
hiv
diseas
cytomegaloviru
cmv
infect
major
problem
stem
cell
solid
organ
transplant
recipi
probabl
common
viral
pneumonia
among
patient
prophylaxi
preemptiv
treatment
regimen
although
variabl
document
frequenc
differ
viral
pathogen
diagnos
etiolog
agent
pneumonia
specif
seri
frequent
pathogen
influenza
viru
influenza
b
viru
rsv
addit
parainfluenza
virus
adenoviru
coronavirus
rhinoviru
also
may
caus
pneumonia
human
metapneumoviru
hmpv
recent
bocaviru
recogn
pathogen
rarer
pathogen
cmv
varicellazost
viru
vzv
herp
simplex
viru
hsv
rubeola
viru
measl
viru
hantaviru
frequent
viral
pathogen
implic
caus
pneumonia
increas
mortal
influenza
viru
serotyp
b
especi
respons
outbreak
respiratori
ganapathi
iyer
parameswaran
l
sanjay
sethi
section
infecti
diseas
viral
influenzarel
ill
occur
outsid
usual
influenza
season
special
risk
factor
sever
diseas
mortal
recogn
pregnanc
sever
obes
recent
pandem
infect
million
person
unit
state
alon
caus
approxim
death
worldwid
sever
infect
consist
pneumonia
acut
respiratori
distress
syndrom
ard
typic
seen
adult
median
age
year
true
incid
pneumonia
influenza
respiratori
infect
unknown
patient
influenzarel
ill
evalu
manag
outpati
without
radiograph
group
elderli
adult
high
vaccin
rate
greater
hospit
influenzarel
ill
radiograph
confirm
pneumonia
signific
proport
patient
ill
congest
heart
failur
precipit
hospit
pneumonia
develop
influenza
infect
one
two
type
primari
viral
pneumonia
postinfluenza
bacteri
pneumonia
louria
cowork
report
pandem
describ
four
syndrom
lower
respiratori
tract
ill
due
influenza
new
york
citi
influenza
ill
physic
sign
lower
respiratori
involv
infiltr
chest
film
influenza
ill
follow
bacteri
pneumonia
acut
rapidli
progress
pneumonia
due
influenza
viru
concomit
viral
bacteri
pneumonia
histopatholog
chang
influenzarel
viral
infect
lower
respiratori
tract
consist
desquam
tracheobronchi
epithelium
alveolar
duct
dilat
hyalin
membran
cover
alveolar
surfac
hemorrhag
inflammatori
infiltr
alveolar
space
interstitium
associ
influenza
lower
respiratori
infect
bacteri
pneumonia
strike
influenzaassoci
ill
winter
minor
chang
hemagglutinin
neuraminidas
protein
viru
caus
antigen
drift
respons
season
influenza
outbreak
although
peopl
age
expos
infect
consequ
influenzaspecif
respiratori
infect
sever
certain
group
patientselderli
person
nurs
home
resid
infant
sever
coexist
cardiac
respiratori
diseas
congest
heart
failur
chronic
obstruct
pulmonari
diseas
copd
pregnant
women
patient
immunosuppress
due
hematolog
malign
hiv
diseas
death
attribut
season
influenza
occur
group
addit
obes
associ
sever
diseas
higher
mortal
recent
pandem
major
mutat
hemagglutinin
neuraminidas
result
antigen
shift
respons
pandem
recent
describ
current
swine
origin
viru
pandem
start
contrast
season
influenza
proport
death
younger
patient
year
increas
pandem
increas
mortal
attribut
lack
previou
exposur
similar
strain
viru
correspond
lack
protect
antibodi
patient
aliv
time
earlier
outbreak
similar
viru
pattern
seen
current
pandem
thu
influenzarel
pneumonia
occur
year
fall
winter
spring
season
consequ
infect
circul
season
influenza
virus
distinct
pattern
pandem
influenza
virus
caus
pneumonia
explos
outbreak
pandem
viral
pneumonia
differ
season
diseas
sever
way
patient
year
age
especi
age
group
affect
often
season
diseas
mortal
due
influenzarel
pneumonia
increas
among
adult
year
age
proport
primari
viral
pneumonia
higher
season
diseas
influenzarel
pneumonia
due
bacteria
typic
clinic
cours
primari
viral
pneumonia
describ
progress
initi
upper
respiratori
tract
symptom
short
breath
increas
cough
sputum
respiratori
failur
compar
secondari
bacteri
pneumonia
period
improv
initi
influenza
infect
follow
new
worsen
respiratori
symptom
due
pneumonia
sputum
often
thin
bloodstain
primari
viral
pneumonia
radiograph
usual
show
bilater
interstiti
infiltr
opac
may
mimic
appear
congest
heart
failur
long
consid
pathogen
children
rsv
recogn
signific
pathogen
elderli
immunocompromis
adult
second
common
pathogen
seri
viral
pneumonia
similar
influenza
virus
rsv
caus
winter
outbreak
respiratori
ill
estim
popul
nurs
home
resid
approxim
develop
rsv
respiratori
infect
year
selflimit
upper
respiratori
infect
remain
develop
pneumonia
center
diseas
control
prevent
cdc
surveil
data
suggest
rsv
infect
respons
death
annual
elderli
patient
live
commun
one
prospect
seri
elderli
adult
rsv
respons
pathogen
patient
hospit
pneumonia
winter
month
chest
radiograph
often
show
bilater
fluffi
infiltr
sinc
describ
caus
respiratori
ill
children
hmpv
recogn
caus
pneumonia
adult
especi
elderli
patient
cardiopulmonari
diseas
prospect
studi
use
revers
transcriptas
pcr
test
nasopharyng
sampl
found
evid
hmpv
infect
adult
hospit
pneumonia
influenza
season
evid
hmpv
infect
present
pcr
analysi
nasopharyng
aspir
andor
pair
serolog
sampl
adult
visit
emerg
depart
canada
pneumonia
exacerb
copd
parainfluenza
virus
caus
upper
respiratori
infect
well
pneumonia
elderli
adult
especi
nurs
home
resid
studi
sweden
found
serolog
evid
recent
parainfluenza
viru
infect
approxim
communityacquir
pneumonia
elderli
person
sever
coronaviru
strain
caus
common
cold
winter
month
pneumonia
describ
elderli
person
immunocompromis
patient
frequenc
infect
known
novel
strain
sarscov
spread
around
globe
caus
acut
pneumonia
ard
frequent
caus
common
cold
thought
pathogen
lower
respiratori
tract
howev
advent
molecular
method
realtim
pcr
analysi
bacteri
pneumonia
caus
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
includ
methicillinresist
strain
frequent
sever
primari
bacteri
pneumonia
due
pathogen
season
incid
pneumonia
infect
commun
parallel
incid
influenza
ill
mechan
underli
increas
frequenc
sever
influenzaassoci
bacteri
pneumonia
mostli
unclear
present
emerg
evid
suggest
role
multipl
viral
host
factor
increas
apoptosi
desquam
airway
epitheli
cell
infect
influenza
viru
expos
multipl
surfac
adhesin
pathogen
bacteria
influenza
virus
express
proapoptot
protein
interfer
mitochondri
function
increas
epitheli
cell
apoptosi
increas
suscept
pneumonia
infect
infect
viral
strain
lack
mice
less
suscept
bacteri
pneumonia
compar
infect
wildtyp
viral
strain
moreov
influenza
infect
decreas
efficaci
airway
mucociliari
clearanc
thu
clearanc
pathogen
bacteria
viral
neuraminidas
increas
bacteri
growth
dissemin
adher
pneumonia
airway
epitheli
cell
mous
model
influenza
strain
high
neuraminidas
activ
associ
higher
mortal
bacteri
infect
influenza
viru
inhibit
neutrophil
chemotaxi
phagocyt
capac
inhibit
induct
macrophag
receptor
collagen
structur
marco
product
macrophag
marco
scaveng
protein
involv
macrophag
recognit
kill
bacteria
influenza
viru
also
caus
desensit
tolllik
receptor
tlr
desensit
persist
sever
week
true
incid
primari
influenza
pneumonia
unknown
mani
patient
undergo
radiographi
detail
clinic
evalu
origin
consid
death
influenza
pandem
due
primari
viral
pneumonia
later
analysi
multipl
data
sourc
howev
strongli
suggest
major
death
approxim
influenzarel
pneumonia
due
secondari
bacteri
postinfluenza
pneumonia
caus
primarili
pneumonia
h
influenza
gramneg
organ
klebsiella
pneumonia
escherichia
coli
seri
patient
influenzarel
pneumonia
death
pandem
show
major
death
due
bacteri
pneumonia
patient
acquir
bacteri
pneumonia
influenza
ill
six
primari
viral
pneumonia
isol
influenza
viru
bacteri
pathogen
lung
tissu
nine
concomit
bacteri
viral
pneumonia
recent
viru
pandem
initi
report
suggest
death
mostli
due
viral
pneumonia
analysi
autopsi
lung
specimen
show
approxim
death
bacteri
pathogen
could
identifi
molecular
studi
howev
proport
viral
pneumonia
approxim
strike
higher
previou
pandem
moreov
aureu
especi
methicillinresist
aureu
mrsa
found
signific
proport
bacteri
pneumonia
high
mortal
especi
among
teenag
patient
therefor
summari
primari
viral
well
secondari
bacteri
infect
includ
due
mrsa
must
consid
everi
case
influenzarel
pneumonia
treat
presumpt
full
identif
pathogen
involv
obtain
demonstr
mani
patient
especi
chronic
respiratori
diseas
copd
immunosuppress
rhinoviru
present
lower
airway
pneumonia
role
rhinoviru
sole
pathogen
causat
pneumonia
still
matter
debat
research
pneumonia
associ
chickenpox
adult
wellrecogn
complic
continu
occur
year
unit
state
chickenpox
occur
adult
incid
pneumonia
complic
increas
approxim
children
except
rare
instanc
pneumonia
associ
rash
typic
diseas
studi
militari
recruit
reveal
radiograph
lung
abnorm
much
common
sign
symptom
pneumoniathat
lung
involv
subclin
mortal
rate
sever
pneumonia
lead
respiratori
failur
decreas
last
decad
owe
improv
ventilatori
support
prompt
therapi
acyclovir
viral
pneumonia
gener
clinic
symptom
cough
short
breath
increas
sputum
chest
pain
sign
radiograph
consolid
fever
tachycardia
tachypnea
reduc
arteri
oxygen
satur
bacteri
pneumonia
clinic
featur
occur
often
viral
pneumonia
bacteri
pneumonia
although
distinct
precis
enough
diagnosi
made
clinic
evalu
without
test
except
rare
situat
patient
viral
pneumonia
tend
older
frailer
comorbid
condit
cardiac
failur
copd
less
chest
pain
tachycardia
fever
show
lower
level
leukocytosi
characterist
clinic
pictur
bacteri
pneumonia
featur
rhiniti
conjunct
pharyng
typic
rash
varicella
measl
point
viral
etiolog
pneumonia
gastrointestin
complaint
often
accompani
influenzarel
infect
rsv
infect
like
associ
wheez
influenza
viru
infect
chest
radiograph
show
lobar
infiltr
basal
atelectasislik
pattern
infiltr
often
bilater
featur
specif
enough
howev
allow
clinic
differenti
viral
bacteri
pneumonia
varicella
pneumonia
often
caus
nodular
lung
lesion
chest
film
although
interstiti
infiltr
also
describ
difficulti
differenti
viral
bacteri
pneumonia
clinic
featur
alon
illustr
studi
compar
find
chest
radiograph
children
communityacquir
pneumonia
children
alveolar
infiltr
bacteri
caus
proven
bacteri
pneumonia
alveolar
infiltr
interstiti
infiltr
approxim
bacteri
caus
ct
scan
show
varieti
appearancesground
glass
opac
nodul
lobular
segment
infiltr
serum
procalcitonin
level
increasingli
use
guid
decis
regard
need
antibacteri
therapi
low
level
may
indic
low
likelihood
bacteri
infect
lower
respiratori
infect
associ
howev
impli
caus
viral
establish
viral
caus
anoth
diagnost
method
cultur
pcr
assay
still
necessari
accuraci
clinic
featur
predict
viral
infect
depend
pretest
probabl
viral
respiratori
infect
given
popul
one
seri
patient
seek
emerg
urgent
care
acut
respiratori
symptom
influenza
season
clinic
judgment
sensit
specif
respect
diagnos
influenza
figur
improv
patient
present
within
hour
symptom
onset
patient
viral
pneumonia
howev
often
accompani
upper
respiratori
symptom
symptom
sign
overlap
bacteri
pneumonia
attempt
precis
definit
role
frequenc
virus
caus
pneumonia
hamper
difficulti
viral
cultur
nihilist
attitud
among
medic
profession
stem
lack
effect
therapi
mani
virus
precis
diagnosi
viral
caus
pneumonia
multipl
benefit
public
health
measur
spread
highli
infect
virus
influenza
virus
rsv
better
coordin
attempt
develop
effect
therapi
support
increas
recognit
etiolog
role
virus
unnecessari
antibiot
therapi
curtail
infect
control
prophylaxi
measur
implement
hospit
nurs
home
varieti
clinic
specimen
suitabl
diagnosi
viral
pneumonia
includ
order
prefer
lung
tissu
bal
fluid
nasopharyng
wash
sampl
nasopharyng
swab
sputum
bal
often
avoid
invas
natur
nevertheless
desir
immunocompromis
critic
ill
patient
specif
diagnosi
necessari
coinfect
common
diagnosi
viral
infect
patient
pneumonia
attempt
one
four
method
summar
tabl
cultur
viru
clinic
specimen
use
tissu
cultur
cell
remain
standard
diagnost
modal
howev
laborintens
requir
expertis
cultur
techniqu
recognit
effect
viru
cell
alway
avail
except
larg
laboratori
send
specimen
refer
laboratori
problemat
mani
virus
toler
transport
poorli
moreov
virus
rhinoviru
hmpv
coronavirus
grow
poorli
tissu
cultur
result
viral
cultur
take
sever
day
becom
avail
caveat
suitabl
specimen
avail
cultur
attempt
sampl
obtain
patient
suspect
viral
pneumonia
shell
vial
cultur
especi
combin
immunofluoresc
antibodi
stain
cell
higher
sensit
tube
cultur
serolog
test
mainstay
retrospect
diagnosi
viral
infect
remain
import
epidemiolog
tool
howev
owe
requir
pair
sampl
separ
week
demonstr
signific
increas
igg
titer
serolog
studi
rare
use
clinic
diagnosi
viral
pneumonia
antigen
detect
perform
respiratori
secret
use
direct
fluoresc
antibodi
dfa
enzymat
immunoassay
eia
test
dfa
test
perform
treat
sampl
virusspecif
antibodi
tag
fluorophor
fluoresc
microscop
often
use
conjunct
shell
vial
cultur
virus
respiratori
secret
eia
avail
detect
influenza
viru
kit
form
administr
use
intraven
small
seri
patient
neuraminidas
inhibitor
effect
reduc
durat
symptom
outpati
influenzarel
upper
respiratori
infect
start
within
hour
onset
symptom
efficaci
influenza
pneumonia
unclear
larg
canadian
studi
adult
hospit
season
influenzarel
infect
show
reduct
mortal
hospit
stay
oseltamivir
start
even
later
hour
cdc
current
recommend
neuraminidas
inhibitor
treatment
adult
sever
influenzarel
ill
seem
reason
therefor
use
one
agent
patient
suspect
influenzarel
pneumonia
whatev
durat
symptom
etiolog
investig
way
approach
also
mean
patient
possibl
viral
pneumonia
season
influenza
season
influenza
pandem
receiv
oseltamivir
appropri
studi
undertaken
identifi
specif
etiolog
agent
pneumonia
zanamivir
altern
oseltamivir
avail
inhal
zanamivir
provok
wheez
clog
nebul
cdc
advis
use
agent
nebul
probabl
avoid
patient
respiratori
compromis
increas
resist
oseltamivir
report
influenza
viru
strain
remain
sensit
zanamivir
peramivir
oseltamivir
less
activ
influenza
b
viru
influenza
viru
zanamivir
prefer
influenza
b
viru
known
etiolog
agent
absenc
contraind
use
incid
resist
oseltamivir
unit
state
remain
low
report
cdc
less
april
http
wwwcdcgovfluweekli
patient
respond
deterior
oseltamivir
drug
resist
suspect
intraven
peramivir
avail
cdc
recent
uncontrol
case
seri
show
promis
result
patient
use
intraven
peramivir
drug
sensit
test
cultur
viral
strain
avail
refer
laboratori
cdc
ribavirin
activ
rsv
howev
efficaci
rsvrelat
lower
respiratori
infect
adult
unprov
limit
evid
efficaci
come
small
case
seri
patient
immunocompromis
state
hematopoiet
stem
cell
transplant
patient
undergo
chemotherapi
leukemia
use
adult
critic
ill
pneumonia
proven
rsv
infect
consid
care
involv
physician
experi
use
ribavirin
situat
ribavirin
aerosol
often
combin
intraven
immunoglobulin
treat
rapid
influenza
diagnosi
test
ridt
although
highli
specif
rapid
test
lower
sensit
approxim
compar
viral
cultur
molecular
method
especi
viral
load
low
rapid
antigen
detect
test
avail
rsv
sensit
low
compar
cultureonli
molecular
method
depend
detect
virusspecif
genet
materi
revers
transcriptas
pcr
rtpcr
nucleic
acid
sequencebas
amplif
nasba
realtim
rtpcr
method
use
method
sensit
specif
similar
often
better
viral
cultur
realtim
pcr
result
avail
day
distinguish
strain
commerci
avail
test
use
multipl
primer
allow
test
panel
virus
becom
common
larg
laboratori
xtag
rvp
assay
approv
us
food
drug
administr
fda
test
virus
commonli
implic
respiratori
ill
even
broader
test
use
panvir
gene
microarray
use
research
tool
may
soon
avail
clinic
use
patient
suspect
clinic
ground
influenza
pneumonia
test
influenza
use
ridt
result
test
neg
viral
cultur
respiratori
secret
nasopharyng
swab
wash
sampl
bal
fluid
endotrach
aspir
perform
avail
nucleic
acid
amplif
test
pcr
assay
perform
specimen
patient
suspect
unknown
viral
pneumonia
viral
cultur
avail
multiplex
viral
pcr
assay
indic
pneumonia
caus
aforement
virus
effect
treatment
avail
due
influenza
b
virus
vzv
possibl
rsv
avail
antivir
drug
adamantan
amantadin
rimantadin
neuraminidas
inhibitor
oseltamivir
zanamivir
provid
cdc
casebycas
basi
peramivir
ribavarin
acyclovir
deriv
valganciclovir
famciclovir
adamantanesamantadin
rimantadinear
longer
recommend
treatment
influenza
owe
widespread
resist
viru
strain
use
treatment
viral
pneumonia
neuraminidas
inhibitor
oseltamivir
avail
oral
zanamivir
inhal
powder
peramivir
intraven
formul
ribavirin
avail
oral
formul
liquid
aerosol
lower
respiratori
infect
although
may
reason
extend
approach
patient
seriou
immunocompromis
condit
solid
organ
transplant
prolong
steroid
therapi
ribavirin
use
elderli
patient
identifi
immunocompromis
condit
base
anecdot
report
approach
casebycas
basi
advic
physician
experienc
treatment
rsv
infect
advanc
molecular
method
diagnosi
increas
awar
recognit
role
virus
caus
pneumonia
immunocompet
well
immunosuppress
adult
list
virus
capabl
caus
pneumonia
increas
although
current
therapeut
option
mostli
limit
influenza
infect
increas
recognit
viral
pneumonia
underli
pathogenet
mechan
would
spur
research
develop
effect
vari
therapi
sever
rsv
infect
immunocompromis
patient
addit
test
wait
result
initi
treatment
bacteri
pneumonia
ad
ribavirin
caus
hemolyt
anemia
aerosol
use
introduc
hospit
staf
problem
agent
teratogen
anim
experi
accident
exposur
women
reproduct
age
must
avoid
vzv
pneumonia
antivir
treatment
intraven
acyclovir
given
everi
patient
suspect
influenzarel
lower
respiratori
infect
bacteri
pneumonia
due
pneumonia
h
influenza
aureu
includ
mrsa
major
consider
bacteri
cultur
perform
antibiot
effect
pathogen
prescrib
probabl
major
reason
underdiagnosi
viral
pneumonia
inappropri
low
level
clinic
suspicion
correspond
lack
laboratori
test
influenza
season
pandem
outbreak
clinic
manag
plan
everi
patient
pneumonia
includ
consider
viral
pneumonia
similarli
pneumonia
immunosuppress
patient
elderli
nurs
home
resid
rais
suspicion
viral
caus
patient
suspect
influenzarel
pneumonia
bacteri
infect
especi
due
pneumonia
h
influenza
aureu
includ
mrsa
consider
laboratori
test
initi
treatment
possibl
distinguish
viral
bacteri
pneumonia
certainti
clinic
examin
alon
diagnos
viral
lower
respiratori
infect
use
upper
respiratori
sampl
nasopharyng
wash
inevit
rais
question
whether
identifi
viru
involv
lower
respiratori
infect
remain
area
explor
pend
data
clinic
judgment
whether
viru
detect
upper
respiratori
sampl
might
respons
pneumonia
necessari
seriou
pathogen
influenza
viru
detect
patient
pneumonia
prudent
approach
assum
patient
viral
possibl
secondari
bacteri
pneumonia
treat
accordingli
situat
much
less
clear
cut
less
wellestablish
lower
respiratori
tract
pathogen
hmpv
bocaviru
rhinoviru
recent
evid
show
high
viral
load
nasopharyng
sampl
determin
use
quantit
pcr
assay
correl
increas
chanc
lower
respiratori
diseas
due
viru
test
commonli
avail
although
good
evid
support
efficaci
antivir
drug
treatment
influenzarel
pneumonia
treatment
rsv
infect
adult
ribavirin
controversi
highqual
control
trial
ribavirin
adult
date
base
small
uncontrol
case
seri
expert
opinion
favor
use
ribavirin
intraven
immunoglobulin
hematopoiet
stem
cell
transplant
recipi
rsvrelat
